DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ advanced 2.92% to $0.70 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.13% to 25,913.90 and the Dow Jones Industrial Average rising 1.32% to 53,178.41.
This was the stock's second consecutive day of gains.
Inovio Pharmaceuticals Inc. closed 76.61% below its 52-week high of $2.98, which the company achieved on September 9th.
The stock outperformed some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.76% to $254.41, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 0.08% to $25.03.
Trading volume (7.6 M) eclipsed its 50-day average volume of 2.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 3, 2026.
Comments